Cytek Biosciences (CTKB) Non Operating Investment Income (2022 - 2026)
Cytek Biosciences' (CTKB) quarterly Non Operating Investment Income came in at -$201000.0 in Q1 2026, down 209.23% YoY from $184014.1 in Q1 2025, and down 628.95% on a QoQ basis from $38000.0 in Q4 2025.
Cytek Biosciences (CTKB) Non Operating Investment Income (2022 - 2026) Analysis & Trends
Cytek Biosciences (CTKB) has 5 years of Non Operating Investment Income data on file, last reported at -$201000.0 in Q1 2026.
- Quarterly Non Operating Investment Income fell 209.23% year-over-year to -$201000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$78000.0 (down 216.42% YoY) and the FY2025 annual result came in at $58000.0, down 40.21% from the prior year.
- Non Operating Investment Income fell to -$201000.0 in Q1 2026, from $38000.0 in the prior quarter.
- In the past five years, Non Operating Investment Income ranged from a high of $195000.0 in Q3 2024 to a low of -$201000.0 in Q1 2026.
- A 5-year average of -$4071.4 and a median of -$9500.0 in 2023 frame the typical range for Non Operating Investment Income.
- The widest YoY moves for Non Operating Investment Income: up 1200.0% in 2024, down 1466.67% in 2024.
- Tracing CTKB's Non Operating Investment Income over 5 years: stood at $17000.0 in 2022, then plunged by 117.65% to -$3000.0 in 2023, then tumbled by 1466.67% to -$47000.0 in 2024, then soared by 180.85% to $38000.0 in 2025, then slumped by 628.95% to -$201000.0 in 2026.
- The last three Non Operating Investment Income figures came in at -$201000.0 (Q1 2026), $38000.0 (Q4 2025), and $118000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Investment Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.07 Bn | 193.46 Bn | 7.27 Bn | - |
| 2 | Stryker | 127.90 Bn | 124.43 Bn | 4.50 Bn | - |
| 3 | Medtronic | 118.84 Bn | 109.62 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 73.33 Bn | 72.79 Bn | 3.85 Bn | - |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn | - |
| 6 | Dexcom | 34.46 Bn | 32.51 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.91 Bn | 31.81 Bn | 2.18 Bn | - |
| 8 | Koninklijke Philips | 26.36 Bn | 23.04 Bn | 4.55 Bn | - |
| 9 | Steris | 23.12 Bn | 22.64 Bn | 684.20 Mn | - |
| 10 | Cytek Biosciences | 609.76 Mn | 535.91 Mn | 28.34 Mn | -147,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -147,000.00 |
| Jun 30, 2026 | -147,000.00 |
| Mar 31, 2026 | -201,000.00 |
| Mar 31, 2026 | -201,000.00 |
| Dec 31, 2025 | 38,000.00 |
| Dec 31, 2025 | 38,000.00 |
| Sep 30, 2025 | 118,000.00 |
| Sep 30, 2025 | 118,000.00 |
| Jun 30, 2025 | -33,000.00 |
| Jun 30, 2025 | -33,000.00 |
| Mar 31, 2025 | -65,000.00 |
| Mar 31, 2025 | -65,000.00 |
| Dec 31, 2024 | -47,000.00 |
| Dec 31, 2024 | -47,000.00 |
| Sep 30, 2024 | 195,000.00 |
| Sep 30, 2024 | 195,000.00 |
| Jun 30, 2024 | -16,000.00 |
| Jun 30, 2024 | -16,000.00 |
| Mar 31, 2024 | -35,000.00 |
| Mar 31, 2024 | -35,000.00 |